Oncology Therapeutics / NCI

Verified Pharmaceutical Manufacturer & Oncology Drug Supplier

Back to Pharmaceuticals Directory

Oncology Therapeutics / NCI

Verified Partner

Registered pharmaceutical manufacturer and healthcare technology supplier listed on the ONC-ORG national directory.

Company Profile & Registration

Legal Organization NameOncology Therapeutics / NCI

Manufacturer Identification CodeRegistered

Authorized RepresentativeCorporate Representative

Compliance & StatusActive / Listed

Oncology Drugs & Clinical Formulations

Featured Drug Formulation

Margenza

Generic: Margetuximab-cmkb

Class: HER2-Directed Monoclonal Antibody

View Complete Drug Profile

Indications: HER2-overexpressing Breast Cancer, metastatic Gastric Cancer, and gastroesophageal junction adenocarcinoma.

Direct Communication & Assistance

Send an Inquiry to Oncology Therapeutics / NCI

Our oncology navigation desk will route your inquiry regarding medicine access, clinical partnerships, or product availability to the appropriate representative.